Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inga Nehlmeier

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Journal of Virology|October 14, 2011
Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like proteaseStephanie Bertram, Ilona Glowacka, Marcel A Müller, et al.
The Lancet. Microbe|June 6, 2025
Host cell entry and neutralisation sensitivity of SARS-CoV-2 BA.3.2Lu Zhang, Amy Kempf, Inga Nehlmeier, et al.
Mbio|April 25, 2022
Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 TherapyMarkus Hoffmann, Anzhalika Sidarovich, Prerna Arora, et al.
Cell Reports|April 27, 2022
SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccinationPrerna Arora, Amy Kempf, Inga Nehlmeier, et al.
Viruses|February 28, 2023
TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron InfectionKristin Metzdorf, Henning Jacobsen, Marina C Greweling-Pils, et al.
Plos Pathogens|May 28, 2024
Macrophage- and CD4+ T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivityChristina B Karsten, Falk F R Buettner, Samanta Cajic, et al.
Viruses|November 11, 2022
Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1Anzhalika Sidarovich, Nadine Krüger, Cheila Rocha, et al.
Cellular & Molecular Immunology|October 26, 2021
The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiencyPrerna Arora, Cheila Rocha, Amy Kempf, et al.
Vaccines|November 26, 2024
Comparative Analysis of Host Cell Entry Efficiency and Neutralization Sensitivity of Emerging SARS-CoV-2 Lineages KP.2, KP.2.3, KP.3, and LB.1Nianzhen Chen, Katharina Emma Decker, Sebastian R Schulz, et al.
Cell|January 13, 2022
The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemicMarkus Hoffmann, Nadine Krüger, Sebastian Schulz, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Journal of Virology|October 14, 2011
Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like proteaseStephanie Bertram, Ilona Glowacka, Marcel A Müller, et al.
The Lancet. Microbe|June 6, 2025
Host cell entry and neutralisation sensitivity of SARS-CoV-2 BA.3.2Lu Zhang, Amy Kempf, Inga Nehlmeier, et al.
Mbio|April 25, 2022
Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 TherapyMarkus Hoffmann, Anzhalika Sidarovich, Prerna Arora, et al.
Cell Reports|April 27, 2022
SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccinationPrerna Arora, Amy Kempf, Inga Nehlmeier, et al.
Viruses|February 28, 2023
TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron InfectionKristin Metzdorf, Henning Jacobsen, Marina C Greweling-Pils, et al.
Plos Pathogens|May 28, 2024
Macrophage- and CD4+ T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivityChristina B Karsten, Falk F R Buettner, Samanta Cajic, et al.
Viruses|November 11, 2022
Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1Anzhalika Sidarovich, Nadine Krüger, Cheila Rocha, et al.
Cellular & Molecular Immunology|October 26, 2021
The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiencyPrerna Arora, Cheila Rocha, Amy Kempf, et al.
Vaccines|November 26, 2024
Comparative Analysis of Host Cell Entry Efficiency and Neutralization Sensitivity of Emerging SARS-CoV-2 Lineages KP.2, KP.2.3, KP.3, and LB.1Nianzhen Chen, Katharina Emma Decker, Sebastian R Schulz, et al.
Cell|January 13, 2022
The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemicMarkus Hoffmann, Nadine Krüger, Sebastian Schulz, et al.
Pageof 8